Treatments for ovarian cancer have changed little over the past few decades, with surgery and chemotherapy being the most common therapeutic approaches.
Researchers at Moffitt Cancer Center want to improve their understanding of the immune environment in ovarian cancer in hopes of making immunotherapy an option